Journal Of Chemotherapy

Journal Of Chemotherapy英文簡介

The Journal of Chemotherapy is an international multidisciplinary journal committed to the rapid publication of high quality, peer-reviewed, original research on all aspects of antimicrobial and antitumor chemotherapy.

The Journal publishes original experimental and clinical research articles, state-of-the-art reviews, brief communications and letters on all aspects of chemotherapy, providing coverage of the pathogenesis, diagnosis, treatment, and control of infection, as well as the use of anticancer and immunomodulating drugs.

Specific areas of focus include, but are not limited to:

· Antibacterial, antiviral, antifungal, antiparasitic, and antiprotozoal agents;

· Anticancer classical and targeted chemotherapeutic agents, biological agents, hormonal drugs, immunomodulatory drugs, cell therapy and gene therapy;

· Pharmacokinetic and pharmacodynamic properties of antimicrobial and anticancer agents;

· The efficacy, safety and toxicology profiles of antimicrobial and anticancer drugs;

· Drug interactions in single or combined applications;

· Drug resistance to antimicrobial and anticancer drugs;

· Research and development of novel antimicrobial and anticancer drugs, including preclinical, translational and clinical research;

· Biomarkers of sensitivity and/or resistance for antimicrobial and anticancer drugs;

· Pharmacogenetics and pharmacogenomics;

· Precision medicine in infectious disease therapy and in cancer therapy;

· Pharmacoeconomics of antimicrobial and anticancer therapies and the implications to patients, health services, and the pharmaceutical industry.

Journal Of Chemotherapy中文簡介

《Journal Of Chemotherapy》是一本由TAYLOR & FRANCIS LTD出版商出版的專業(yè)醫(yī)學(xué)期刊，該刊創(chuàng)刊于1989年，刊期Bimonthly，該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄。在中科院最新升級版分區(qū)表中，該刊分區(qū)信息為大類學(xué)科：醫(yī)學(xué) 4區(qū)，小類學(xué)科：傳染病學(xué) 4區(qū)；腫瘤學(xué) 4區(qū)；藥學(xué) 4區(qū)；在JCR（Journal Citation Reports）分區(qū)等級為Q4。該刊發(fā)文范圍涵蓋傳染病學(xué)等領(lǐng)域，旨在及時、準(zhǔn)確、全面地報(bào)道國內(nèi)外傳染病學(xué)工作者在該領(lǐng)域取得的最新研究成果、工作進(jìn)展及學(xué)術(shù)動態(tài)、技術(shù)革新等，促進(jìn)學(xué)術(shù)交流，鼓勵學(xué)術(shù)創(chuàng)新。2021年影響因子為2.385，平均審稿速度較慢,6-12周。

中科院分區(qū)最新升級版（當(dāng)前數(shù)據(jù)版本：2021年12月最新升級版）

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)	Top期刊	綜述期刊
醫(yī)學(xué)	4區(qū)	INFECTIOUS DISEASES 傳染病學(xué) ONCOLOGY 腫瘤學(xué) PHARMACOLOGY & PHARMACY 藥學(xué)	4區(qū) 4區(qū) 4區(qū)	否	否

JCR分區(qū)（當(dāng)前數(shù)據(jù)版本：2021-2022年最新版）

JCR分區(qū)等級	JCR所屬學(xué)科	分區(qū)	影響因子
Q4	INFECTIOUS DISEASES	Q4	2.385
	PHARMACOLOGY & PHARMACY	Q4
	ONCOLOGY	Q4

期刊指數(shù)

影響因子	h-index	Gold OA文章占比	研究類文章占比	OA開放訪問	平均審稿速度
2.385	45	1.38%	72.97%	未開放	較慢,6-12周

IF值(影響因子)趨勢圖